Animal models of Sjogren's syndrome

被引:24
|
作者
Jonsson, Malin V.
Delaleu, Nicolas
Jonsson, Roland
机构
[1] Univ Bergen, Gade Inst, Broegelmann Res Lab, N-5021 Bergen, Norway
[2] Univ Bergen, Dept Oral Sci Oral Pathol & Forens Odontol, Bergen, Norway
[3] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway
关键词
Sjogren's syndrome; animal models; sialadenitis; MRL; NOD; Id3; Ro; BAFF;
D O I
10.1007/s12016-007-8012-7
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Sjogren's syndrome is an autoimmune, chronic inflammatory disease characterized by focal mononuclear cell infiltration of exocrine tissues, accompanied by loss of secretory function. The pathogenesis of autoimmune diseases is complex and, therefore, difficult to study in vitro. As of today, the role of initiating factors remains obscure, clinical symptoms develop late, and there are no tests for early diagnosis of SS. Hence, the disease is difficult to detect and treat. Animal models may provide insights into the identification of target antigens, narrowing the relevant pathological immune mechanisms, and to study the evolution of tissue pathology. This review summarizes current knowledge on murine strains, both spontaneous and induced models, used to study Sjogren's syndrome. Special attention is paid to the characteristics of different strains regarding their properties to mimic specific aspects or stages of the disease.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 50 条
  • [21] Sjogren's syndrome
    Delaleu, N
    Jonsson, R
    Koller, MM
    EUROPEAN JOURNAL OF ORAL SCIENCES, 2005, 113 (02) : 101 - 113
  • [22] Effect of lymphotoxin blockage on different stages of Sjogren's syndrome in an animal model
    Jacob, Alexander
    Shen, Long
    He, Jing
    Nealon, Kelly
    Alexander, Jessy J.
    Ambrus, Julian L., Jr.
    RHEUMATOLOGY & AUTOIMMUNITY, 2022, 2 (02): : 76 - 81
  • [23] Sjogren's Syndrome
    Mavragani, Clio P.
    Moutsopoulos, Haralampos M.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9, 2014, 9 : 273 - 285
  • [24] Experimental models of Sjogren's syndrome: differences and similarities with human disease
    Kaklamanos, A.
    Goules, A. V.
    Tzioufas, A. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 2398 - 2412
  • [25] Rituximab Therapy in Primary Sjogren's Syndrome
    Alcantara, Cristina
    Gomes, Maria Joao
    Ferreira, Carlos
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 701 - 705
  • [26] Sjogren's-like syndrome in a dog
    Nabeta, Rina
    Kambe, Naoki
    Nakagawa, Yuki
    Chiba, Shiori
    Hou Xiantao
    Furuya, Tetsuya
    Kishimoto, Miori
    Uchide, Tsuyoshi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2019, 81 (06) : 886 - 889
  • [27] Sjogren's syndrome: a systemic autoimmune disease
    Negrini, Simone
    Emmi, Giacomo
    Greco, Monica
    Borro, Matteo
    Sardanelli, Federica
    Murdaca, Giuseppe
    Indiveri, Francesco
    Puppo, Francesco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 22 (01) : 9 - 25
  • [28] Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: An animal study
    Li, Chun Lei
    He, Jing
    Li, Zhan Guo
    Zheng, Li Wu
    Hua, Hong
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2013, 41 (07) : 610 - 615
  • [29] Sjogren's syndrome: Terminology
    Oxholm, P
    Asmussen, K
    Axell, T
    VanBijsterveld, OP
    Jacobsson, L
    Konttinen, Y
    Manthorpe, R
    Nederfors, T
    Prause, JU
    Schiodt, M
    Thorn, JJ
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 (06) : 693 - 696
  • [30] Pathophysiology of Sjogren's syndrome
    Garcia-Carrasco, Mario
    Fuentes-Alexandro, Salvador
    Escarcega, Ricardo O.
    Salgado, Gonzalo
    Riebeling, Carlos
    Cervera, Ricard
    ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (08) : 921 - 932